Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark

Acta Psychiatrica Scandinavica

Volumn 129, Issue 3, 2014, Pages 221-231

  Steinhausen, H C ^a,b,c   Bisgaard, C ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adolescents; Antidepressives; Antipsychotics; Anxiolytics; Children; Psychopharmacology; Stimulants

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ARTICLE; CHILD; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; AGE; MENTAL DISORDERS; REGISTER; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AGE FACTORS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DENMARK; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; REGISTRIES; SEX FACTORS;

EID: 84893785568     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12155     Document Type: Article

References (26)

1. Zito JM, Safer DJ, de Jong-van den Berg LT, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2008;2:26.
2. Zito JM, Tobi H, de Jong-van den Berg LT et al. Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 2006;15:793-798.
3. Percudani M, Barbui C, Fortino I, Petrovich L. Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom 2005;74:189-190.
4. Wong IC, Murray ML, Camilleri-Novak D, Stephens P. Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 2004;89:1131-1132.
5. Hugtenburg JG, Heerdink ER, Egberts AC. Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 2004;60:377-379.
6. Zito JM, Safer DJ, Dosreis S et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003;157:17-25.
7. Zuvekas SH, Vitiello B. Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 2012;169:160-166.
8. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001;108:E25.
9. Knellwolf AL, Deligne J, Chiarotti F et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 2008;64:311-317.
10. Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 2011;123:360-367.
11. Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among U.S. children, 1997-2002. J Am Acad Child Adolesc Psychiatry 2006;45:271-279.
12. Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001;23:262-267.
13. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 2006;16:197-206.
14. Rani F, Murray ML, Byrne PJ, Wong IC. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008;121:1002-1009.
15. Pringsheim T, Lam D, Patten SB. The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009. J Child Adolesc Psychopharmacol 2011;21:537-543.
16. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679-685.
17. Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML. Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol 2002;12:221-229.
18. Vitiello B. An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 2008;20:121-126.
19. Mors O, Perto GP, Mortensen PB. The Danish psychiatric central research register. Scand J Public Health 39:54-57.
20. Lindemann C, Langner I, Kraut AA et al. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 2012;22:307-314.
21. Novik TS, Hervas A, Ralston SJ, Dalsgaard S, Rodrigues PR, Lorenzo MJ. Influence of gender on attention-deficit/hyperactivity disorder in Europe-ADORE. Eur Child Adolesc Psychiatry 2006;15:I15-I24.
22. Jane CE, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 2006;47:1263-1271.
23. Lauritsen MB, Jorgensen M, Madsen KM et al. Validity of childhood autism in the Danish Psychiatric Central Register: findings from a cohort sample born 1990-1999. J Autism Dev Disord 2010;40:139-148.
24. Jakobsen KD, Frederiksen JN, Hansen T, Jansson LB, Parnas J, Werge T. Reliability of clinical ICD-10 schizophrenia diagnoses. Nord J Psychiatry 2005;59:209-212.
25. Loffler W, Hafner H, Fatkenheuer B et al. Validation of Danish case register diagnosis for schizophrenia. Acta Psychiatr Scand 1994;90:196-203.
26. Kessing L. Validity of diagnoses and other clinical register data in patients with affective disorder. Eur Psychiatry 1998;13:392-398.